Ranibizumab versus verteporfin for neovascular age-related macular degeneration. - Brown DM; Kaiser PK; Michels M; Soubrane G; Heier JS; Kim RY; Sy JP; Schneider S; ANCHOR Study Group; Brown, David M; Kaiser, Peter K; Michels, Mark; et al. (New England Journal of Medicine, 2006)